Alejandro González Veliz: 2026 ESC Guidelines Expand Cardiac Rehabilitation Beyond Post-Event Recovery
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about a recent article by Maria Bäck et al, published in European Heart Journal, adding:
“Cardiac rehabilitation is no longer simply ‘exercise after a heart attack.’
The 2026 ESC Guidelines emphasize cardiac rehabilitation as a comprehensive, patient-centred intervention that combines exercise training with risk-factor management, nutrition, psychological care, medication optimization, physical activity, and long-term lifestyle support.
Its indications extend far beyond ACS, including chronic coronary syndromes, HFrEF and HFpEF, valve interventions, AF, ICD/CRT, congenital heart disease, frailty, and other cardiovascular conditions.
Early initiation matters, when clinically safe.
And delivery is evolving: centre-based, home-based, telerehabilitation, and hybrid models can all play a role.
The key message: rehabilitation is not the final step after cardiovascular treatment — it is part of the treatment itself.”
Title: 2026 ESC Guidelines on cardiac rehabilitation: Developed by the task force on cardiac rehabilitation of the European Society of Cardiology (ESC)
Endorsed by the European Society of Physical and Rehabilitation Medicine (ESPRM) and World Organization of Family Doctors (WONCA)
Authors: Maria Bäck, Matthias Wilhelm, Thimo Marcin, Felipe V C Machado, Anna Sandberg, Sergio Buccheri, Almudena Castro Conde, Michal Czapla, Salvatore De Rosa,
Irene Gibson, Anežka Gombošová, Oleksii Korzh, Maria Teresa La Rovere, Emanuela Teresina Locati, Josep Masip, Tone Merete Norekval, Giuseppina Novo, Roberto F E Pedretti, Anne Grete Semb, Jolanta M Siller-Matula, Chantal F Ski, Simon H Sündermann, Rod S Taylor, Rogier J A Veltrop, Dominique Hansen
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk
-
Sep 9, 2026, 15:39Alessandro Lucchesi: The Future of MPN Disease Modification
-
Sep 9, 2026, 15:10Pablo Corral: Is the Lp(a) Hypothesis Wrong?
-
Sep 9, 2026, 14:54Agnes Kisakye: Expanding Point-of-Care Ultrasound and Surgical Interventions for Hemophilia in Uganda
-
Sep 9, 2026, 14:52Jan Sloves: Addressing Diagnostic and Treatment Variability in Pelvic-Origin Varicose Veins
-
Sep 9, 2026, 14:48The French Care Pathway for Gene Therapy in Haemophilia B – CRH French Reference Center for Hemophilia Lyon
-
Sep 9, 2026, 14:43David McIntosh: The Ethics of Plasma Donation
-
Sep 9, 2026, 14:42Thirunavukkarasu Angappan: Factor VIII and IX Didn’t Get Viral-Safety Rules Until the 1980s
-
Sep 9, 2026, 13:59Natalie Arnold: Biomarkers and the Hidden Burden of CHD